BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
8389 results:

  • 1. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
    Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
    Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
    Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
    J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
    Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
    World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EBV-Associated gastric cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.
    Abolhasani M; Mohseni AO; Shakeri R; Khavanin A; Khajehei M; Omidi A; Geramizadeh B; Shafigh E; Naghshvar F; Fathizadeh P; Taghizadehgan L; Gharib A; Gulley ML; Dawsey SM; Malekzadeh R; Rabkin CS; Vasei M
    Arch Iran Med; 2024 Apr; 27(4):191-199. PubMed ID: 38685845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characteristics of early gastric tumors with different differentiation and predictors of long-term outcomes after endoscopic submucosal dissection.
    Zhu HY; Wu J; Zhang YM; Li FL; Yang J; Qin B; Jiang J; Zhu N; Chen MY; Zou BC
    World J Gastroenterol; 2024 Apr; 30(14):1990-2005. PubMed ID: 38681129
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
    Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
    Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
    Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
    Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
    Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
    [No Abstract]    [Full Text] [Related]  

  • 10. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
    Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
    [No Abstract]    [Full Text] [Related]  

  • 11. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
    Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
    [No Abstract]    [Full Text] [Related]  

  • 12. Endoscopic submucosal dissection for the treatment of a large inflammatory fibroid polyp in the gastric antrum prolapsing into the duodenum: A case report.
    Wang X; Ma R; Ma J; Tang N; Li R; Ma X
    Medicine (Baltimore); 2024 Apr; 103(16):e37877. PubMed ID: 38640263
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
    Yin X; Zhu W; Tang X; Yang G; Zhao X; Zhao K; Jiang L; Li X; Zhao H; Wang X; Yan Y; Xing L; Yu J; Meng X; Zhao H
    BMC Cancer; 2024 Apr; 24(1):486. PubMed ID: 38632501
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pancreatic head resection for carcinoma of the ampulla vateri - better long-term prognosis, but more postoperative complications.
    Kuesters S; Sundheimer J; Wittel UA; Chikhladze S; Fichtner-Feigl S; Biesel EA
    Langenbecks Arch Surg; 2024 Apr; 409(1):129. PubMed ID: 38632147
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review.
    Ntwali F; Gilliaux Q; Honoré PM
    Am J Case Rep; 2024 Apr; 25():e941835. PubMed ID: 38625840
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting cellular senescence as a therapeutic vulnerability in gastric cancer.
    Geng H; Huang C; Xu L; Zhou Y; Dong Z; Zhong Y; Li Q; Yang C; Huang S; Liao W; Lin Y; Liu Z; Li Q; Zhang Z; Zhu C
    Life Sci; 2024 Jun; 346():122631. PubMed ID: 38621585
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk factors for postoperative bleeding following endoscopic submucosal dissection in early gastric cancer: A systematic review and meta-analysis.
    Gu Y; Zhao S
    Medicine (Baltimore); 2024 Apr; 103(15):e37762. PubMed ID: 38608116
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
    Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
    Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Pyloric gland adenoma - a rare tumor of the upper gastrointestinal tract with a high risk of malignancy].
    Tertychnyy AS; Pachuashvili NV; Protsenko DD; Avraamova ST; Nagornaya DP; Pavlov PV; Kiryukhin AP; Fedorenko AA
    Arkh Patol; 2024; 86(2):30-36. PubMed ID: 38591904
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
    Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
    Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 420.